1Life Healthcare, Inc. (ONEM) — Financial statements
Income statement, balance sheet, and cash flow for 1Life Healthcare, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,046↑68.2% | 622↑63.5% | 380↑37.6% | 276↑29.9% | 213 | |
| Cost of Revenue | 861↑97.9% | 435↑85.2% | 235↑40.2% | 168↑23.1% | 136 | |
| Gross Profit | 184↓1.1% | 186↑28.3% | 145↑33.7% | 109↑42.0% | 76 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 416↑28.7% | 323↑105.4% | 157↑44.3% | 109↑27.0% | 86 | |
| Selling & Marketing Expenses | 97↑56.6% | 62↑67.7% | 37↓6.5% | 40↑53.2% | 26 | |
| SG&A Expenses | 513↑33.2% | 385↑98.3% | 194↑30.8% | 148↑33.1% | 112 | |
| Other Expenses | 91↑103.8% | 45↑99.9% | 22↑56.8% | 14↑43.4% | 10 | |
| Operating Expenses | 604↑40.5% | 430↑98.4% | 217↑33.1% | 163↑33.9% | 122 | |
| Total Costs & Expenses | 1,465↑69.4% | 865↑91.6% | 452↑36.7% | 330↑28.2% | 258 | |
| Operating Results | ||||||
| Operating Income | -418↓72.1% | -243↓240.1% | -71↓31.9% | -54↓20.1% | -45 | |
| Depreciation & Amortization | 91↑96.1% | 46↑107.8% | 22↓8.7% | 25↑146.3% | 10 | |
| EBITDA | -324↓65.4% | -196↓265.1% | -54↓87.7% | -29↑14.9% | -34 | |
| EBIT | -416↓71.8% | -242↓217.8% | -76↓43.2% | -53↓18.9% | -45 | |
| Interest & Other Income | ||||||
| Net Interest Income | -10↑25.4% | -13↓11.5% | -12↓388.9% | 4↑178.1% | 1 | |
| Interest Income | 2↑152.5% | 0.80↓55.9% | 2↓59.8% | 4↑99.8% | 2 | |
| Interest Expense | 12↓15.1% | 14↑2.4% | 13↑2734.2% | 0.47↓41.0% | 0.80 | |
| Non-Operating Income | -2↓152.5% | -0.80↓116.8% | 5↑585.3% | -0.98↓161.8% | -0.37 | |
| Other Income / Expenses | -12↑15.1% | -14↑21.3% | -17↓1162.0% | 2↑482.8% | -0.43 | |
| Income Before Tax | -429↓67.4% | -256↓188.7% | -89↓69.3% | -52↓15.4% | -45 | |
| Income Tax Expense | -32↓1648.8% | -2↓1365.0% | -0.12↓241.4% | 0.09↑248.0% | 0.03 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -398↓56.2% | -255↓187.0% | -89↓68.8% | -53↓18.3% | -44 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -398↓56.2% | -255↓187.0% | -89↓68.8% | -53↓18.3% | -44 | |
| Bottom-Line Net Income | -398↓56.2% | -255↓187.0% | -89↓68.8% | -53↓18.3% | -44 | |
| EPS (Basic) | -2.02↓21.7% | -1.66↓121.3% | -0.75↓74.4% | -0.43↑10.4% | -0.48 | |
| EPS (Diluted) | -2.02↓21.7% | -1.66↓121.3% | -0.75↓74.4% | -0.43↑10.4% | -0.48 | |
| Weighted Average Shares | 197↑28.2% | 154↑29.8% | 118↓3.3% | 122↑33.5% | 92 | |
| Weighted Average Diluted Shares | 197↑28.2% | 154↑29.8% | 118↓3.3% | 122↑33.5% | 92 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.